Our blood consists of many cell types that develop through different stages from a precursor type—the blood stem cell. An ...
In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...
Researchers uncover how leukemia drains T cells' energy, paving the way for stronger cancer immunotherapy and enhancing CAR T ...
In atopic dermatitis, psoriasis and other dermatologic diseases, T cells lose tolerance to self-antigens, triggering the autoimmune response that leads to abnormal skin cell proliferation and ...
News Medical on MSN11d
Reprogramming immune cells to improve cancer treatmentSolid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of T cells, scientists at the VIB-KU Leuven Center for Cancer Biology and ...
Discover how the ALA-CART platform enhances CAR T cell efficacy against antigen-low leukemias. With improved LAT activation, ...
Aptevo Therapeutics (APVO) provided an overview of solid tumor anti-cancer compound APVO603, currently in preclinical development for the ...
Rieger: Continuous map of early hematopoietic stem cell differentiation across human lifetime. Nature Communications 16, Article number: 2287 (2025) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback